The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
10 pts

Opinion on  ONYX Pharmaceuticals Inc. (ONXX)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Not selling yet...

Dec 13, 2006 05:40 PM GMT
P9100039
Return Risk
+8.89% HIGH
Analyst

I played my cards right and bought as the stock dropped after Nexavar failed to be approved for the treatment of melanoma.   I was already looking toward the possible approval of uses for other cancers such as liver.



ONYX may pull back into the low 20's over the next few months, but with the buyout possibilities and more firms watching this company (and buying)  I am going to ride out those small bumps.  If it drops below 22 I'll be buying more.     


ONXX:  This call was made on 12/13/06 @ $11.95
Rating:   Positive   $11.95 (12/13/06)
Gain/Loss:   +133.39% in 1073 days
Target:   $15.00 (+25.52%) in Three months
Allocation:   14.2% of portfolio


+ Referring to this analysis:


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

Who voted on this idea?
Gammatester 76% 06/07/2007
Ages
Fatvisionary N/A 05/17/2007


Ratings referring to this analysis Agree     Disagree



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.25% 377
2 18.14 +70.10% 208
3 17.66 +25.70% 55
4 13.47 +14.32% 61
5 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
ONYX Pharmaceuticals Inc. (ONXX)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
86.5%
Top:
50.0%




Latest Picks by Jak1313
Symbol SP Sentiment Rating Return Since
MXWL Positive +41.80% 09/14/07
ITOEF Positive n/a 03/07/07
RHT Positive +69.32% 12/08/06
WAB Neutral/Hold +20.56% 12/05/06
HW Positive -78.34% 11/14/06

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch